{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:20:28Z","timestamp":1790270428395,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.antiviral.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T10:26:21Z","timestamp":1340015181000},"page":"245-256","source":"Crossref","is-referenced-by-count":34,"title":["Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner"],"prefix":"10.1016","volume":"95","author":[{"given":"Jing","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjiao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.06.004_b0005","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.06.004_b0010","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andr\u00e9","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0015","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1462-5822.2007.00972.x","article-title":"Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection","volume":"9","author":"Andr\u00e9o","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0020","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.06.004_b0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1755-5922.2008.00062.x","article-title":"Liver X receptors (LXR) as therapeutic targets in dyslipidemia","volume":"26","author":"Be\u0142towski","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.antiviral.2012.06.004_b0030","first-page":"93","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2012.06.004_b0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0163-7827(98)00017-4","article-title":"Receptor-mediated mechanisms of lipoprotein remnant catabolism","volume":"37","author":"Chappell","year":"1998","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0045","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1194\/jlr.M300135-JLR200","article-title":"The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse","volume":"44","author":"Chisholm","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0050","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of theABC1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"Costet","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.06.004_b0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"Dorner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.06.004_b0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.06.004_b0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jmv.10196","article-title":"Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption","volume":"68","author":"Germi","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0070","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.febslet.2011.07.019","article-title":"Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells","volume":"585","author":"Gong","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2012.06.004_b0075","doi-asserted-by":"crossref","first-page":"19720","DOI":"10.1074\/jbc.M110.123729","article-title":"The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2","volume":"285","author":"Hong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.06.004_b0080","first-page":"760","article-title":"Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications","volume":"61","author":"Jamroz-Wisniewska","year":"2007","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.antiviral.2012.06.004_b0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.06.004_b0090","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.06.004_b0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1194\/jlr.M800376-JLR200","article-title":"Synthetic LXR agonist attenuates plaque formation in apoE\u2212\/\u2212 mice without inducing liver steatosis and hypertriglyceridemia","volume":"50","author":"Kratzer","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2012.06.004_b0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0110","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JVI.01888-08","article-title":"Tight junction proteins claudin-1 and Occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection","volume":"83","author":"Liu","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0115","doi-asserted-by":"crossref","first-page":"32035","DOI":"10.1074\/jbc.M402296200","article-title":"C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles","volume":"279","author":"Lozach","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.06.004_b0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2012.06.004_b0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrd2411","article-title":"The way forward in HCV treatment [mdash] finding the right path","volume":"6","author":"Manns","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2012.06.004_b0130","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.M300450-JLR200","article-title":"Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator","volume":"45","author":"Miao","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhep.2006.09.024","article-title":"The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus","volume":"46","author":"Molina","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO;2-4","article-title":"Low density lipoprotein receptor as a candidate receptor for hepatitis C virus","volume":"57","author":"Monazahian","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.110.065029","article-title":"Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP binding cassette transporter A1","volume":"78","author":"Morrow","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.105.560177","article-title":"Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo","volume":"113","author":"Naik","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2012.06.004_b0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2010.02391.x","article-title":"The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 na\u00efve patients","volume":"31","author":"Nelson","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2012.06.004_b0160","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/JVI.80.5.2418-2428.2006","article-title":"Association between hepatitis C virus and very-low-density lipoprotein (VLDL)\/LDL analyzed in iodixanol density gradients","volume":"80","author":"Nielsen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2012.06.004_b0170","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/JVI.77.7.4070-4080.2003","article-title":"Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR","volume":"77","author":"P\u00f6hlmann","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2005.03.023","article-title":"Enveloped particles in the serum of chronic hepatitis C patients","volume":"336","author":"Petit","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.06.004_b0180","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.06.004_b0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nrgastro.2012.4","article-title":"Hepatitis: NPC1L1 identified as a novel HCV entry factor","volume":"9","author":"Ray","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0190","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.289.5484.1524","article-title":"Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers","volume":"289","author":"Repa","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.06.004_b0195","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000097606.43659.F4","article-title":"Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene: lanosterol cyclase","volume":"93","author":"Rowe","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0200","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1194\/jlr.M500080-JLR200","article-title":"The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver","volume":"46","author":"Sabol","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0205","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.77.1.546-559.2003","article-title":"Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes","volume":"77","author":"Saunier","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0210","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.06.004_b0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.coph.2009.08.008","article-title":"Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities","volume":"9","author":"Shimakami","year":"2009","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.antiviral.2012.06.004_b0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2011.08.015","article-title":"Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir","volume":"52","author":"Susser","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2012.06.004_b0225","first-page":"736","article-title":"Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism","volume":"61","author":"Wojcicka","year":"2007","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.antiviral.2012.06.004_b0230","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1074\/jbc.M706416200","article-title":"Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis","volume":"283","author":"Wong","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.06.004_b0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.virusres.2010.11.009","article-title":"A novel luciferase and GFP dual reporter virus for rapid and convenient evaluation of hepatitis C virus replication","volume":"155","author":"Wu","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2012.06.004_b0240","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T17:50:04Z","timestamp":1642528204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0166354212001453"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.06.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}